Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports
<p dir="ltr">The coronavirus disease 2019 (COVID-19) pandemic has been an enormous public health challenge. The pursuit for an effective therapy led to the use of the antiviral drug Remdesivir for hospitalized patients with severe COVID-19 pneumonia. We reported two cases of patients...
محفوظ في:
| المؤلف الرئيسي: | Alaaeldin Abdelmajid (12535542) (author) |
|---|---|
| مؤلفون آخرون: | Wala Osman (17269054) (author), Huda Musa (17269057) (author), Hisham Elhiday (17269060) (author), Waqar Munir (14506265) (author), Muna A. Al.Maslamani (17269063) (author), Eman Zeyad Elmekaty (17269066) (author) |
| منشور في: |
2021
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Toward Preparing a Knowledge Base to Explore Potential Drugs and Biomedical Entities Related to COVID-19: Automated Computational Approach
حسب: Junaed Younus Khan (16870110)
منشور في: (2020) -
Melatonin-induced symptomatic bradycardia in an otherwise healthy male: a case report
حسب: Asim Alawad (19489015)
منشور في: (2024) -
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
حسب: Ridhima Kaul (12485902)
منشور في: (2021) -
Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients
حسب: Sara Al-Khawaga (4792761)
منشور في: (2020) -
Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study
حسب: Rand A. Alattar (9538554)
منشور في: (2022)